MX2011012233A - Soluciones de retinoide topicas. - Google Patents

Soluciones de retinoide topicas.

Info

Publication number
MX2011012233A
MX2011012233A MX2011012233A MX2011012233A MX2011012233A MX 2011012233 A MX2011012233 A MX 2011012233A MX 2011012233 A MX2011012233 A MX 2011012233A MX 2011012233 A MX2011012233 A MX 2011012233A MX 2011012233 A MX2011012233 A MX 2011012233A
Authority
MX
Mexico
Prior art keywords
topical retinoid
retinoid solutions
solutions
topical
retinoid
Prior art date
Application number
MX2011012233A
Other languages
English (en)
Inventor
Sanjay Kumar Motwani
Shashikanth P Isloor
Vinod Arora
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of MX2011012233A publication Critical patent/MX2011012233A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se relaciona a una solución tópica que comprende un retinoide o sus sales farmacéuticamente aceptables del mismo y a un proceso para prepararla.
MX2011012233A 2009-05-20 2010-05-20 Soluciones de retinoide topicas. MX2011012233A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1039DE2009 2009-05-20
IN2759DE2009 2009-12-31
PCT/IB2010/052255 WO2010134048A2 (en) 2009-05-20 2010-05-20 Topical retinoid solutions

Publications (1)

Publication Number Publication Date
MX2011012233A true MX2011012233A (es) 2012-04-19

Family

ID=54258969

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011012233A MX2011012233A (es) 2009-05-20 2010-05-20 Soluciones de retinoide topicas.

Country Status (9)

Country Link
US (1) US10123970B2 (es)
EP (2) EP2432453A2 (es)
CN (1) CN102458362A (es)
BR (1) BRPI1010972A2 (es)
CA (1) CA2762394C (es)
HK (1) HK1223297A1 (es)
MX (1) MX2011012233A (es)
SG (2) SG176097A1 (es)
WO (1) WO2010134048A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015023497A1 (en) * 2013-08-13 2015-02-19 Access Business Group International Llc Use of fatty acid to reduce skin irritation associated with retinoid therapy
AU2016346203B2 (en) 2015-10-30 2021-05-27 Leo Pharma A/S Isotretinoin formulations and uses and methods thereof
CN110062618B (zh) 2016-12-13 2022-09-13 宝洁公司 包含类视色素的稳定个人护理组合物

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT331797B (de) 1973-03-01 1976-08-25 Wuelfing J A Fa Verfahren zur herstellung des neuen 1,3-bis- (beta-athylhexyl)-5-amino-5-methyl-hexahydropyrimidin-pyridin-3-carboxylats
US4322438A (en) 1979-08-06 1982-03-30 United States Of America Method for the use of orally administered 13-cis-retinoic acid in the treatment of acne
US4593046A (en) 1983-07-15 1986-06-03 Murray Gruber Method of reducing skin irritation from benzoyl peroxide
US4678663A (en) * 1984-02-06 1987-07-07 Nuetrogena Corporation Hydroquinone composition having enhanced bio-availability and percutaneous adsorption
US4888342A (en) 1984-05-16 1989-12-19 Kligman Albert M Methods for treatment of sundamaged human skin with retinoids
CA1282326C (en) 1984-12-14 1991-04-02 Paul J. Jarosz Pharmaceutical composition containing 13-cis vitamin a acid as the active ingredient
DE69029804T2 (de) 1989-06-07 1997-09-04 Gail S Bazzano VEHIKEL MIT LANGSAMER FREISETZUNG ZUR VERMINDERUNG DER HAUTREIZUNG TOPISCHER retinoidhaltiger MITTEL
AU670777B2 (en) 1992-04-16 1996-08-01 Ortho Pharmaceutical Corporation Aqueous gel vehicles for retinoids
US5252604A (en) * 1992-07-10 1993-10-12 Hoffmann-La Roche Inc. Compositions of retinoic acids and tocopherol for prevention of dermatitis
US6503523B2 (en) * 1998-05-07 2003-01-07 Gs Development A.B. Skin care agents containing combinations of active agents consisting of vitamin a derivatives and UBI- or plastoquinones
PE20001227A1 (es) 1998-10-30 2000-11-06 Hoffmann La Roche Procesos para producir una composicion de isotretinoina
US6248354B1 (en) * 1999-03-04 2001-06-19 Allergan Sales, Inc. Capsule system
US6277881B1 (en) 1999-05-27 2001-08-21 Unilever Home & Personal Care, Usa, Division Of Conopco, Inc. Turmeric as an anti-irritant in compositions containing hydroxy acids or retinoids
US6339107B1 (en) 2000-08-02 2002-01-15 Syntex (U.S.A.) Llc Methods for treatment of Emphysema using 13-cis retinoic acid
RU2168996C1 (ru) 2000-09-19 2001-06-20 Фармацевтическое научно-производственное предприятие "Ретиноиды" (акционерное общество закрытого типа) Стабильный раствор ретинола пальмитата и способ лечения заболеваний кожи
DE60104206T2 (de) 2000-09-22 2005-09-22 Galephar M/F Halbfeste arzneizubereitung enthaltend isotretinoin
FR2818905A1 (fr) 2000-12-28 2002-07-05 Cll Pharma Compositions pharmaceutiques colloidales micellaires renfermant un principe actif lipophile
US7211267B2 (en) * 2001-04-05 2007-05-01 Collagenex Pharmaceuticals, Inc. Methods of treating acne
MXPA04005497A (es) * 2001-12-06 2004-10-11 Ranbaxy Lab Ltd Composiciones nanoparticuladas de isotretinoin.
GB0307864D0 (en) * 2003-04-04 2003-05-14 Novartis Ag Pharmaceutical composition
US20050009910A1 (en) 2003-07-10 2005-01-13 Allergan, Inc. Delivery of an active drug to the posterior part of the eye via subconjunctival or periocular delivery of a prodrug
FR2870125B1 (fr) 2004-05-12 2010-03-26 Dermaconcept Jmc Formulation du type spot-on utile en cosmetologie et en dermatologie
US20060177392A1 (en) * 2005-02-10 2006-08-10 William Walden Oil-based composition for acne
US20060241078A1 (en) * 2005-03-16 2006-10-26 Ahmed Salah U Pharmaceutical compositions comprising a contraceptive agent in solution and a teratogen
US20070104780A1 (en) 2005-10-25 2007-05-10 Lipari John M Formulation comprising a drug of low water solubility and method of use thereof
CN101066340B (zh) * 2007-05-16 2012-06-27 苏振芳 复方外用河豚毒素油膏及其制备方法
WO2010008600A1 (en) 2008-07-16 2010-01-21 Dermworx Incorporated Topical drug delivery system
BRPI1010970A2 (pt) 2009-05-20 2019-04-09 Ranbaxy Laboratories Limited solução farmacêutica, processo para preparar uma solução farmacêutica e método para tratamento

Also Published As

Publication number Publication date
WO2010134048A3 (en) 2012-01-12
WO2010134048A2 (en) 2010-11-25
SG176097A1 (en) 2011-12-29
EP3006021A1 (en) 2016-04-13
BRPI1010972A2 (pt) 2019-04-16
CA2762394C (en) 2016-07-19
HK1223297A1 (zh) 2017-07-28
SG2014012173A (en) 2014-07-30
US10123970B2 (en) 2018-11-13
EP2432453A2 (en) 2012-03-28
CN102458362A (zh) 2012-05-16
US20120259014A1 (en) 2012-10-11
CA2762394A1 (en) 2010-11-25

Similar Documents

Publication Publication Date Title
MY182428A (en) Crystalline forms of a prolyl hydroxylase inhibitor
TN2013000411A1 (en) Branched 3-phenylpropionic acid derivatives and the use thereof
MY170302A (en) Process for the preparation of an aqueous solution comprising at least one earth alkali hydrogen carbonate and its use
EA033455B1 (ru) Кристаллические формы замещенных 5-фтор-1h-пиразолопиридинов, способы их получения, их применение для получения лекарственного средства, лекарственное средство и способ лечения на их основе
IN2012DN00422A (es)
WO2011079193A3 (en) Preparation of bendamustine and its salts
MY150014A (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
UA106386C2 (ru) Способ синтеза ивабрадина и его аддитивных солей с фармацевтически приемлемой кислотой
IN2012DE00289A (es)
WO2012174229A3 (en) Methods for the synthesis and purification of deoxycholic acid
MX2011012233A (es) Soluciones de retinoide topicas.
MY145611A (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
MD4375C1 (ro) Procedeu de sinteză enzimatică a (7S)-1-(3,4-dimetoxibiciclo[4.2.0]octa-1,3,5-trien-7-il)-N-metil-metanaminei şi aplicarea în sinteza ivabradinei şi a sărurilor sale
JO2854B1 (en) A new method for the synthesis of anfabradine and its added salts with acid is pharmaceutically acceptable.
UA110626C2 (uk) Спосіб одержання пан-інгібіторів циклінзалежної кінази формули (i), а також проміжні продукти цього процесу одержання
MY170662A (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
MX345278B (es) Procedimiento de sintesis del 3,4-dimetoxibiciclo[4.2.0]octa-1,3,5 -trien-7-carbonitrilo, y aplicacion a la sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable.
IN2013CH04314A (es)
WO2013083226A8 (de) Porenarmes, wasserfreies natriumcarbonat
MX347536B (es) Procedimiento de sintesis enzimatica del acido (7s)-3,4-dimetoxibiciclo[4.2.0]octa-1,3,5-trien-7-carboxilico y aplicacion en la sintesis de ivabradina y de sus sales.
MX2013002990A (es) Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable.
MX2014003770A (es) Tetrahidrato de la sal de l-arginina del acido s-(-)-9-fluoro-6,7-dihidro-8-(4-hidroxipiperidin-1-il)-5-metil-1- oxo-1h,5h-benzo[i,j] quinolizin-2-carboxilico puro, y un proceso para su preparacion.
IN2013MU03426A (es)
SI2607354T1 (sl) Nov postopek sinteze ivabradina in njegovih dodatnih soli s farmacevtsko sprejemljivo kislino
UA60666U (en) A process for the preparation of iodofluoromethane

Legal Events

Date Code Title Description
FG Grant or registration